The uniqueness of the Brazilian Yellow Fever Virus. Are the vaccines less effective against it?
P. mamidi, M. Gaur, B. Mishra, B. B. Subudhi, S. Rath, M. Mohanty
Abstract
The years 2016-2019 witnessed the expansion of Yellow Fever Virus (YFV) circulation area in Brazil. Deforestation and mutations in the nsp genes were presumed responsible for the reemergence of YFV in brazil. However, our data analysis involving 200 clinical isolates worldwide including vaccine strains showed two amino acids substitutions exclusively in the Brazilian strains at critical positions (V318A and I335M) in the ED III domain of E protein. Our molecular dynamics analysis involving reference and mutant structures suggests that the mutations significantly changed the conformational rearrangement and folding of the YFV-EDIII domain as revealed by RMSF, PCA, Porcupine plots and secondary structure analysis. Briefly, the regions 324-330, 339-346 and 347-359 had a higher fluctuation than the wild, while regions 313-318 and 379-384 had a lower fluctuation. As reported earlier that the residues E325 and E380 are part of vaccine epitopes and any mutations in these residues reduced the binding of vaccine generated mabs to the epitopes. Hence, it may be speculated from our porcupine plot data analysis that that the commercial YFV vaccines may not be fully effective against the Brazilian strains in particular owing to the fluctuations of these residues. However, future investigation is required to validate the observations.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genomic and structural features of the Yellow Fever virus from the 2016-2017 Brazilian outbreak
M. M. Gomez, F. V. S. de Abreu, … M. C. Bonaldo·bioRxiv·Aug 22, 2017
- Genotype-specific Features Reduce the Susceptibility of South American Yellow Fever Virus Strains to Vaccine-Induced Antibodies
D. Haslwanter, G. Lasso, … K. Chandran·bioRxiv·Aug 22, 2021
- Isolation of a potently neutralizing and protective human monoclonal antibody targeting yellow fever virus
J. E. Crowe, M. Doyle, … M. Diamond·bioRxiv·Feb 28, 2022
- A chimeric Japanese encephalitis vaccine protects against lethal yellow fever virus infection without inducing neutralizing antibodies
N. Mishra, R. Boudewijns, … K. Dallmeier·bioRxiv·Jul 28, 2019
- Prior flavivirus immunity skews the yellow fever vaccine response to expand cross-reactive antibodies with increased risk of antibody dependent enhancement of Zika and dengue virus infection
A. Santos-Peral, F. Luppa, … S. Rothenfusser·bioRxiv·May 7, 2023
- Ecological drivers of sustained enzootic yellow fever virus transmission in Brazil, 2017-2021
N. I. O. Silva, G. F. Albery, … B. P. Drumond·bioRxiv·Oct 19, 2022